Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by JLGeminion Oct 05, 2010 6:18pm
325 Views
Post# 17532269

RE: RE: Well fellow mushrooms - We are ivestors.

RE: RE: Well fellow mushrooms - We are ivestors.

Cardu, we are investors, not mushrooms.  Today was a wild ride but ONCY closed up 8 cents and ONC was up a dime.  Let’s celebrate as investors that the correction rally to over $7 which supports a market of $500 million is continuing.

 

Do not ask Brad to explain the market.  He is CEO of a company.  He gave a good update last week in NY.  On Wednesday, he is presenting again on the West Coast.  He is selling the Oncolytics story.

 

You have to listen to the drum beats of the market.  The correction is crossing the $5.00 Rubicon.  I salute the market players.  They spiked the stock to new 52 week highs that will not be reached again for a number of days.  Why advertise a good thing?  As the correction rally continues there will be more opportunities to acquire stock in Oncolytics.  My thanks go to them.
Bullboard Posts